Skip to main content

Table 2 Angiogenic and inflammation markers of subjects at the time of the trial

From: Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden

Parameter Controls (N = 25) Patients (N = 41) p
VEGF (pg/ml) 36.3. ±8.9 53.8 ± 42.7 0.014
Angiogenin (pg/ml) 1.42 ± 0.38 1.37 ± 0.46 0.318
hs CRP (mg/l) 1.5 +/- 1.4 3.5 +/- 8.1 0.038
IL-6 (ng/ml) 2.5 ± 3.4 4.9 ± 4.1 0.016
IL-8 5.4 +/- 1.3 6.3+/- 3.0 0.102
IL-8 (pg/ml) 5.4 ± 1.3 6.3 ± 3.0 0.102
hs CRP (mg/ml) 1.5 ± 1.4 3.5 ± 8.1 0.038
VCAM-1 (ng/ml) 286.5 ± 60.1 283.3 ± 52.1 0.336
ICAM-1 (ng/ml) 182.3 ± 50.3 190.9 ± 44.9 0.775
Selectin-P (ng/ml) 52.9 ± 10.9 55.1 ± 13.4 0.373
Selectin-E (ng/ml) 44.7 ± 12.5 47.4 ± 14.8 0.112
TNF-α (ng/ml) 1.19 ± 1.12 0.93 ± 1.0 0.780
  1. Values are shown as means and standard deviations; VEGF-vascular endothelial growth factor, IL-6 – interleukin 6, IL-8 – interleukin 8, hsCRP – high sensitive C-reactive protein, VCAM-1 – vascular cell adhesion molecule-1, ICAM-1 – intracellular adhesion molecule-1, TNF-α – tumour necrosis factor α.